NovoCure ( NVCR - Free Report ) closed the last trading session at $18.31, gaining 2.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $35.14 indicates a 91.9% upside potential.